John Sheets

John W. Sheets

Director of the Office of Device Evaluation at Food and Drug Administration

Location:
5600 Fishers Lane, Rockville, Maryland, United States
HQ Phone:
(240) 276-9300

General Information

Experience

President - The Hoya

Chief Scientific Officer - Anika Therapeutics , Inc.

Worldwide Vice President, Research and Development and Chief Technical Officer - Ethicon , Inc.

Expert Consultant - NDA Partners LLC

Senior Vice President, Corporate Research - Boston Scientific Corporation

Consulting On Strategy, Innovation and Development - Portfolio of Medical Device and Pharmaceutical Companies CVP, Global R&D & CTO

President - Hoya Corporation

Vice President, Surgical Research and Development - Alcon , Inc.

Education

B.S.University of Florida , Gainesville

M.S.University of Florida , Gainesville

Ph.D. - Materials Science and Engineering , University of Florida

Program for Management Development graduateHarvard University

Affiliations

Board Member - InnFocus Inc

Member - Society For Biomaterials

Inaugural Member - Florida Life Sciences Council Advisory Board for Enterprise Florida

Corporate Vice President and Chief Technology Officer - Bausch & Lomb Canada Inc.

Recent News  

R&Q Intelligence Tour Cleveland

John Sheets, Former FDA/CDRH Director, Office of Device Evaluation
The Case for Quality has transformed into to a movement for quality beyond compliance. John Sheets, Former FDA John Sheets FDA Approval Process Former FDA/CDRH Director, Office of Device Evaluation John W Sheets, Jr., Ph.D. is a dynamic business and technical leader in the medical device, pharmaceutical and biotech industries. Recently John has served as Director, Office of Device Evaluation at Center for Devices and Radiological Health at FDA. Previously, Dr. Sheets was CEO at Fenovision (ophthalmic drug delivery start-up) and Chief Technology Officer at Anika Therapeutics (biotech products based on hyaluronic acid). As Senior VP, Corporate Research at Boston Scientific, he revitalized product innovation by introducing the biodesign process and identifying new growth markets which were sourced through a global partnership network. John also led ETHICON R&D as CTO, created the biosurgical platform and restructured the pipeline which led to double-digit business growth.

Read More
R&Q Intelligence Tour Minneapolis

John Sheets, Former FDA/CDRH Director, Office of Device Evaluation
The Case for Quality has transformed into to a movement for quality beyond compliance. John Sheets, Former FDA John Sheets FDA Compliance Former FDA/CDRH Director, Office of Device Evaluation John W Sheets, Jr., Ph.D. is a dynamic business and technical leader in the medical device, pharmaceutical and biotech industries. Recently John has served as Director, Office of Device Evaluation at Center for Devices and Radiological Health at FDA. Previously, Dr. Sheets was CEO at Fenovision (ophthalmic drug delivery start-up) and Chief Technology Officer at Anika Therapeutics (biotech products based on hyaluronic acid). As Senior VP, Corporate Research at Boston Scientific, he revitalized product innovation by introducing the biodesign process and identifying new growth markets which were sourced through a global partnership network. John also led ETHICON R&D as CTO, created the biosurgical platform and restructured the pipeline which led to double-digit business growth.

Read More
R&Q Intelligence Tour Cleveland

John Sheets, Former FDA/CDRH Director, Office of Device Evaluation
The Case for Quality has transformed into to a movement for quality beyond compliance. John Sheets, Former FDA John W Sheets, Jr., Ph.D. is a dynamic business and technical leader in the medical device, pharmaceutical and biotech industries. Recently John has served as Director, Office of Device Evaluation at Center for Devices and Radiological Health at FDA. Previously, Dr. Sheets was CEO at Fenovision (ophthalmic drug delivery start-up) and Chief Technology Officer at Anika Therapeutics (biotech products based on hyaluronic acid). As Senior VP, Corporate Research at Boston Scientific, he revitalized product innovation by introducing the biodesign process and identifying new growth markets which were sourced through a global partnership network. John also led ETHICON R&D as CTO, created the biosurgical platform and restructured the pipeline which led to double-digit business growth.

Read More

Browse ZoomInfo’s Directories